Incidence of Postradioiodine Immunogenic Hyperthyroidism/Graves' Disease in Relation to a Temporary Increase in Thyrotropin Receptor Antibodies After Radioiodine Therapy for Autonomous Thyroid Disease-Reference-Cited by-同舟云学术

Incidence of Postradioiodine Immunogenic Hyperthyroidism/Graves' Disease in Relation to a Temporary Increase in Thyrotropin Receptor Antibodies After Radioiodine Therapy for Autonomous Thyroid Disease

Published:2006-03 Issue:3 Volume:16 Page:281-288
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Schmidt Matthias¹,Gorbauch Eva¹,Dietlein Markus¹,Faust Michael²,Stützer Hartmut³,Eschner Wolfgang¹,Theissen Peter¹,Schicha Harald¹

Affiliation:

1. Department of Nuclear Medicine, Informatics and Epidemiology, University of Cologne, Cologne, Germany.

2. Department II of Internal Medicine, Informatics and Epidemiology, University of Cologne, Cologne, Germany.

3. Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2006.16.281

Reference36 articles.

1. Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2)

2. Guideline for radioiodine therapy for benign thyroid diseases (version 3)

3. Prevalence of Thyroid Disorders in the Working Population of Germany: Ultrasonography Screening in 96,278 Unselected Employees

4. PATHOLOGICAL ANATOMY OF EXOPHTHALMIC GOITER

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DGN-Handlungsempfehlung (S1-Leitlinie): Radiojodtherapie bei benignen Schilddrüsenerkrankungen (Stand 6/2022 – AWMF-Registernummer: 031-003) – Radiojodtherapie bei benignen Schilddrüsenerkrankungen;Nuklearmedizin - NuclearMedicine;2023-10-23

2. The EANM guideline on radioiodine therapy of benign thyroid disease;European Journal of Nuclear Medicine and Molecular Imaging;2023-07-03

3. Diagnostics and Theranostics of Benign Thyroid Disorders;Integrated Diagnostics and Theranostics of Thyroid Diseases;2023

4. Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case Report;Frontiers in Nuclear Medicine;2022-03-15

5. Radionuclide Therapy in Benign Thyroid Diseases: Nodular Goiter Disease;Radionuclide Therapy;2022